Source: Journal of Cardiac Failure. Conference titles: Heart Failure Society of America's (HFSA) Annual Scientific Meeting. Unidades: FMRP, FM, ICB
Subjects: CARDIOPATIAS, DOENÇA CRÔNICA, DOENÇA DE CHAGAS, EPIDEMIOLOGIA EXPERIMENTAL
ABNT
TANAKA, Denise Mayumi et al. Pentoxifylline reduces inflammation and myocardial perfusion derangements in experimental chronic Chagas cardiomyopathy in hamsters. Journal of Cardiac Failure. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 28 abr. 2026. , 2022APA
Tanaka, D. M., Fabricio, C. G., Marin Neto, J. A., Barros Filho, A. C. L. de, Lopes, C. D., Oliveira, L. F. L. de, et al. (2022). Pentoxifylline reduces inflammation and myocardial perfusion derangements in experimental chronic Chagas cardiomyopathy in hamsters. Journal of Cardiac Failure. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.cardfail.2022.03.271NLM
Tanaka DM, Fabricio CG, Marin Neto JA, Barros Filho ACL de, Lopes CD, Oliveira LFL de, Resende AA de, Moreira HT, Mejia J, Higuchi ML, Cunha Neto E, Romano MMD, Schmidt A, Simões MV. Pentoxifylline reduces inflammation and myocardial perfusion derangements in experimental chronic Chagas cardiomyopathy in hamsters. Journal of Cardiac Failure. 2022 ; 28( 5S): S106-S107.[citado 2026 abr. 28 ]Vancouver
Tanaka DM, Fabricio CG, Marin Neto JA, Barros Filho ACL de, Lopes CD, Oliveira LFL de, Resende AA de, Moreira HT, Mejia J, Higuchi ML, Cunha Neto E, Romano MMD, Schmidt A, Simões MV. Pentoxifylline reduces inflammation and myocardial perfusion derangements in experimental chronic Chagas cardiomyopathy in hamsters. Journal of Cardiac Failure. 2022 ; 28( 5S): S106-S107.[citado 2026 abr. 28 ]
